FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1786645224> ?p ?o ?g. }

• W1786645224 endingPage "431" @default.
• W1786645224 startingPage "430" @default.
• W1786645224 abstract "In their editorial, Ghosh et al. are critical of National Institute for Health and Clinical Excellence (NICE) Medical Technology Guidance 3 on CardioQ™ Oesophageal Doppler monitoring, but their description of the facts and their analysis are inaccurate [1]. Medical technologies guidance is different in its context and intent from other NICE publications and it is important that these differences are clearly understood. The NICE medical technologies programme aims to identify technologies that offer advantages to patients and to the service over ‘current management’. Its focus on the claims of specific commercial products (which may have a short market life) is fundamental to developing guidance quickly for the NHS. Moreover, consideration of the issues and uncertainties in the case for adoption of a specific product can help to guide practice in general and the use of other technologies that are claimed to offer similar benefits. Manufacturers notify potential topics; they are not identified by members of the Medical Technologies Advisory Committee (MTAC), which is an advisory body, independent of NICE. The Medical Technologies Advisory Committee is responsible for selecting notified products for which NICE guidance is likely to be of value to the NHS. Submissions are not prepared by NICE’s contracted external assessment centres; these academic centres provide independent critiques of submissions prepared by manufacturers. There is no requirement for hospital trusts to ‘report back to NICE’; medical technology guidance recommends whether trusts should consider adopting technologies, based on clear statements about their likely clinical and cost advantages. Ghosh et al. question the robustness of the evidence base on which the recommendations were made. Evidence for medical devices and diagnostic tests is typically sparse (specifically compared with pharmaceuticals and especially if a technology is relatively new). The NICE medical technologies programme aims to stimulate the development of more and better quality evidence by working with manufacturers and by fostering research. Ghosh et al. criticise manufacturer funding for many of the trials and researchers. It is to the credit of manufacturers when they do fund trials. The Medical Technologies Advisory Committee considers all the features of trial evidence, irrespective of funding source, on the basis of quality, robustness, quantity and potential sources of bias. Ghosh et al. also point out that outcome measures and patient groups were heterogeneous among the available studies; in our experience, this is a common characteristic of clinical evidence, which is why we have developed a deliberative, structured and balanced approach to decision-making. The wide range of clinicians, scientists, lay people and other disciplines on MTAC aims to provide the necessary skills and expertise to weigh evidence and other factors, and to make difficult judgements. The advice of clinical experts is a very important part of the information available to the Committee in making its recommendations. Experts are nominated by stakeholders, including professional societies and manufacturers, and there are robust processes for managing conflicts of interest. We encourage specialist clinicians, including Ghosh and colleagues, to become involved in future medical technology evaluations by seeking to be nominated as experts in their specialty. We would also encourage clinical experts to respond to public consultation, which is a very influential step in the production of NICE guidance." @default.
• W1786645224 created "2016-06-24" @default.
• W1786645224 creator A5007949786 @default.
• W1786645224 creator A5017416460 @default.
• W1786645224 date "2012-03-12" @default.
• W1786645224 modified "2023-09-23" @default.
• W1786645224 title "Oesophageal Doppler monitoring: the role of NICE" @default.
• W1786645224 cites W2190183497 @default.
• W1786645224 doi "https://doi.org/10.1111/j.1365-2044.2012.07105.x" @default.
• W1786645224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22409800" @default.
• W1786645224 hasPublicationYear "2012" @default.
• W1786645224 type Work @default.
• W1786645224 sameAs 1786645224 @default.
• W1786645224 citedByCount "2" @default.
• W1786645224 countsByYear W17866452242012 @default.
• W1786645224 countsByYear W17866452242013 @default.
• W1786645224 crossrefType "journal-article" @default.
• W1786645224 hasAuthorship W1786645224A5007949786 @default.
• W1786645224 hasAuthorship W1786645224A5017416460 @default.
• W1786645224 hasBestOaLocation W17866452241 @default.
• W1786645224 hasConcept C110894328 @default.
• W1786645224 hasConcept C127413603 @default.
• W1786645224 hasConcept C151730666 @default.
• W1786645224 hasConcept C154945302 @default.
• W1786645224 hasConcept C160735492 @default.
• W1786645224 hasConcept C162324750 @default.
• W1786645224 hasConcept C17744445 @default.
• W1786645224 hasConcept C184356942 @default.
• W1786645224 hasConcept C187736073 @default.
• W1786645224 hasConcept C199360897 @default.
• W1786645224 hasConcept C199539241 @default.
• W1786645224 hasConcept C207267971 @default.
• W1786645224 hasConcept C21333345 @default.
• W1786645224 hasConcept C2777352838 @default.
• W1786645224 hasConcept C2779256446 @default.
• W1786645224 hasConcept C2779343474 @default.
• W1786645224 hasConcept C3017489713 @default.
• W1786645224 hasConcept C41008148 @default.
• W1786645224 hasConcept C50522688 @default.
• W1786645224 hasConcept C71924100 @default.
• W1786645224 hasConcept C86803240 @default.
• W1786645224 hasConcept C88463610 @default.
• W1786645224 hasConceptScore W1786645224C110894328 @default.
• W1786645224 hasConceptScore W1786645224C127413603 @default.
• W1786645224 hasConceptScore W1786645224C151730666 @default.
• W1786645224 hasConceptScore W1786645224C154945302 @default.
• W1786645224 hasConceptScore W1786645224C160735492 @default.
• W1786645224 hasConceptScore W1786645224C162324750 @default.
• W1786645224 hasConceptScore W1786645224C17744445 @default.
• W1786645224 hasConceptScore W1786645224C184356942 @default.
• W1786645224 hasConceptScore W1786645224C187736073 @default.
• W1786645224 hasConceptScore W1786645224C199360897 @default.
• W1786645224 hasConceptScore W1786645224C199539241 @default.
• W1786645224 hasConceptScore W1786645224C207267971 @default.
• W1786645224 hasConceptScore W1786645224C21333345 @default.
• W1786645224 hasConceptScore W1786645224C2777352838 @default.
• W1786645224 hasConceptScore W1786645224C2779256446 @default.
• W1786645224 hasConceptScore W1786645224C2779343474 @default.
• W1786645224 hasConceptScore W1786645224C3017489713 @default.
• W1786645224 hasConceptScore W1786645224C41008148 @default.
• W1786645224 hasConceptScore W1786645224C50522688 @default.
• W1786645224 hasConceptScore W1786645224C71924100 @default.
• W1786645224 hasConceptScore W1786645224C86803240 @default.
• W1786645224 hasConceptScore W1786645224C88463610 @default.
• W1786645224 hasIssue "4" @default.
• W1786645224 hasLocation W17866452241 @default.
• W1786645224 hasLocation W17866452242 @default.
• W1786645224 hasOpenAccess W1786645224 @default.
• W1786645224 hasPrimaryLocation W17866452241 @default.
• W1786645224 hasRelatedWork W1786645224 @default.
• W1786645224 hasRelatedWork W1986680670 @default.
• W1786645224 hasRelatedWork W2019601163 @default.
• W1786645224 hasRelatedWork W2387831760 @default.
• W1786645224 hasRelatedWork W2586098917 @default.
• W1786645224 hasRelatedWork W2803402278 @default.
• W1786645224 hasRelatedWork W2905136166 @default.
• W1786645224 hasRelatedWork W3102511946 @default.
• W1786645224 hasRelatedWork W4210481047 @default.
• W1786645224 hasRelatedWork W4311496522 @default.
• W1786645224 hasVolume "67" @default.
• W1786645224 isParatext "false" @default.
• W1786645224 isRetracted "false" @default.
• W1786645224 magId "1786645224" @default.
• W1786645224 workType "article" @default.